1

                                                                    EXHIBIT 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (Nos. 33-76236 and 33-93668 pertaining to the 1993
Directors' Stock Option Plan of Incyte Pharmaceuticals, Inc.; Nos. 33-76344,
33-93666, 333-13449, 333-31413 and 333-63069 pertaining to the 1991 Stock Plan
of Incyte Pharmaceuticals, Inc.; No. 333-31409 pertaining to the Incyte
Pharmaceuticals, Inc. 1997 Employee Stock Purchase Plan; and No. 333-46639
pertaining to the Options Assumed by Incyte Pharmaceuticals, Inc. Originally
Granted Under the Synteni, Inc. 1996 Equity Incentive Plan) of Incyte
Pharmaceuticals, Inc. of our report dated January 17, 2000 relating to the
financial statements of diaDexus, LLC, which appears in this Form 10-K.


\s\ PricewaterhouseCoopers LLP

San Jose, California
March 20, 2000